Market cap
₹201 Cr
Recently Viewed
Clear AllBSE: 531569
₹163.30
₹-0.75
(-0.46%)
As on 29-Apr-2026IST
Market cap
₹201 Cr
Revenue (TTM)
₹74 Cr
P/E Ratio
24.3
P/B Ratio
4.2
Div. Yield
0.3 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹8 Cr
ROE
25.9 %
ROCE
29.2 %
Industry P/E
30.6
EV/EBITDA
17.1
Debt to Equity
0.2
Book Value
₹38.8
EPS
₹6.8
Face value
10
Shares outstanding
12,284,300
CFO
₹30.85 Cr
EBITDA
₹-53.39 Cr
Net Profit
₹-72.66 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sanjivani Pa
| -29.5 | 16.9 | -6.8 | -31.5 | 42.4 | 70.3 | 17.0 |
|
BSE Healthcare
| 2.8 | 5.2 | 8.2 | 4.9 | 24.7 | 13.9 | 11.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Sanjivani Pa
| -39.3 | 111.5 | 363.0 | 3.5 | 263.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sanjivani Pa
|
163.3 | 200.6 | 73.6 | 8.3 | 14.4 | 20 | 24.3 | 4.2 |
| 2,804.2 | 35,045.7 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.5 | 7.6 | |
| 8,369.0 | 20,952.5 | 2,177.5 | 200.9 | 11.3 | 26.5 | 104.3 | 25.2 | |
| 1,727.6 | 13,117.3 | 2,089.5 | 622.0 | 31.3 | 20.4 | 21.4 | 3.9 | |
| 1,690.2 | 10,331.2 | 1,196.4 | 149.4 | -- | 27.5 | 69.1 | 14.7 | |
| 1,316.2 | 18,223.9 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.2 | 5.0 | |
| 2,061.2 | 33,122.5 | 4,193.0 | 753.8 | 22.7 | 20.8 | 43.9 | 8.3 | |
| 4,763.0 | 21,794.9 | 2,482.3 | 853.6 | 33.7 | 18.9 | 25.5 | 5.5 | |
| 5,135.0 | 8,509.3 | 1,348.5 | 293.5 | 28.1 | 50.7 | 29 | 12.2 | |
| 1,053.5 | 9,708.1 | 4,725.6 | 528.7 | 14.9 | 20.7 | 19 | 3.3 |
No Review & Analysis are available.
Manufacture of allopathic pharmaceutical preparations
Incorporated
1994
Chairman
Ashwani Khemka
Managing Director
Ashwani Khemka
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Sanjivani Paranteral Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Sanjivani Paranteral Ltd is ₹163.30 (BSE) as of 29-Apr-2026 IST. Sanjivani Paranteral Ltd has given a return of 42.39% in the last 3 years.
The P/E ratio of Sanjivani Paranteral Ltd is 24.26 times as on 29-Apr-2026, a 21 discount to its peers’ median range of 30.60 times.
The P/B ratio of Sanjivani Paranteral Ltd is 4.21 times as on 29-Apr-2026, a 9 discount to its peers’ median range of 4.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
35.17
|
7.77
|
|
2024
|
28.44
|
6.78
|
|
2023
|
9.18
|
-13.49
|
|
2022
|
13.51
|
-8.64
|
|
2021
|
6.59
|
-0.21
|
The 52-week high and low of Sanjivani Paranteral Ltd are Rs 268.80 and Rs 132.50 as of 29-Apr-2026.
Sanjivani Paranteral Ltd has a market capitalisation of ₹ 201 Cr as on 29-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Sanjivani Paranteral Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.